Glyceraldehyde-3-Phosphate Dehydrogenases
"Glyceraldehyde-3-Phosphate Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD.
| Descriptor ID |
D005987
|
| MeSH Number(s) |
D08.811.682.657.163.750
|
| Concept/Terms |
Glyceraldehyde-3-Phosphate Dehydrogenases- Glyceraldehyde-3-Phosphate Dehydrogenases
- Dehydrogenases, Glyceraldehyde-3-Phosphate
- Triosephosphate Dehydrogenase
- Dehydrogenase, Triosephosphate
- Phosphoglyceraldehyde Dehydrogenase
- Dehydrogenase, Phosphoglyceraldehyde
- GAPD
- Glyceraldehydephosphate Dehydrogenase
- Dehydrogenase, Glyceraldehydephosphate
|
Below are MeSH descriptors whose meaning is more general than "Glyceraldehyde-3-Phosphate Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "Glyceraldehyde-3-Phosphate Dehydrogenases".
This graph shows the total number of publications written about "Glyceraldehyde-3-Phosphate Dehydrogenases" by people in this website by year, and whether "Glyceraldehyde-3-Phosphate Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glyceraldehyde-3-Phosphate Dehydrogenases" by people in Profiles.
-
A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product. Cell Metab. 2017 Oct 03; 26(4):648-659.e8.
-
Effective elimination of cancer stem cells by a novel drug combination strategy. Stem Cells. 2013 Jan; 31(1):23-34.
-
A versatile method for cell-specific profiling of translated mRNAs in Drosophila. PLoS One. 2012; 7(7):e40276.
-
2D-PCR: a method of mapping DNA in tissue sections. Lab Chip. 2009 Dec 21; 9(24):3526-34.
-
Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Res. 2009 Apr; 37(7):2346-58.
-
Stability of placental RNA using dried maternal blood spots. Reprod Biomed Online. 2008 Nov; 17(5):716-21.
-
GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell. 2007 Jun 01; 129(5):983-97.
-
Differential expression of survivin splice isoforms in medulloblastomas. Neuropathol Appl Neurobiol. 2007 Feb; 33(1):67-76.
-
Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res. 2006 Apr 28; 98(8):1032-9.
-
Substrate preferences and glucose uptake in glibenclamide-resistant Leishmania parasites. Comp Biochem Physiol C Toxicol Pharmacol. 2005 Mar-Apr; 140(3-4):395-402.